These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36476848)

  • 1. The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2/PI3K-mediated regulation of MYC.
    Lee JS; Lero MW; Mercado-Matos J; Zhu S; Jo M; Tocheny CE; Morgan JS; Shaw LM
    Cell Rep; 2022 Dec; 41(10):111759. PubMed ID: 36476848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel Invasion-Promoting Region in Insulin Receptor Substrate 2.
    Mercado-Matos J; Janusis J; Zhu S; Chen SS; Shaw LM
    Mol Cell Biol; 2018 Jul; 38(14):. PubMed ID: 29685905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irs2 inactivation suppresses tumor progression in Pten+/- mice.
    Szabolcs M; Keniry M; Simpson L; Reid LJ; Koujak S; Schiff SC; Davidian G; Licata S; Gruvberger-Saal S; Murty VV; Nandula S; Efstratiadis A; Kushner JA; White MF; Parsons R
    Am J Pathol; 2009 Jan; 174(1):276-86. PubMed ID: 19095950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent tagging of endogenous IRS2 with an auxin-dependent degron to assess dynamic intracellular localization and function.
    Jo M; Lee JS; Tocheny CE; Lero MW; Bui QT; Morgan JS; Shaw LM
    J Biol Chem; 2024 Sep; 300(11):107796. PubMed ID: 39305958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin signaling pathway protects neuronal cell lines by Sirt3 mediated IRS2 activation.
    Mishra N; Lata S; Deshmukh P; Kamat K; Surolia A; Banerjee T
    Biofactors; 2018 May; 44(3):224-236. PubMed ID: 29411439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.
    Zhou W; Rowitz BM; Dailey MJ
    Exp Biol Med (Maywood); 2018 Jul; 243(11):911-916. PubMed ID: 29950119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
    Guo S; Dunn SL; White MF
    Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
    Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
    Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation.
    Law NC; Hunzicker-Dunn ME
    J Biol Chem; 2016 Feb; 291(9):4547-60. PubMed ID: 26702053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway
    Zhao H; Lu J; He F; Wang M; Yan Y; Chen B; Xie D; Xu C; Wang Q; Liu W; Yu W; Xi Y; Yu L; Yamamoto T; Koyama H; Wang W; Zhang C; Cheng J
    Front Immunol; 2022; 13():931087. PubMed ID: 36177037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
    Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
    J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.
    Zhu Y; Pereira RO; O'Neill BT; Riehle C; Ilkun O; Wende AR; Rawlings TA; Zhang YC; Zhang Q; Klip A; Shiojima I; Walsh K; Abel ED
    Mol Endocrinol; 2013 Jan; 27(1):172-84. PubMed ID: 23204326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of protein tyrosine phosphatase 1B increases IGF-I receptor tyrosine phosphorylation but does not rescue retinal defects in IRS2-deficient mice.
    Arroba AI; Revuelta-Cervantes J; Menes L; González-Rodríguez Á; Pardo V; de la Villa P; Burks DJ; Valverde ÁM
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4215-25. PubMed ID: 23702782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt3a regulates proliferation, apoptosis and function of pancreatic NIT-1 beta cells via activation of IRS2/PI3K signaling.
    Gui S; Yuan G; Wang L; Zhou L; Xue Y; Yu Y; Zhang J; Zhang M; Yang Y; Wang DW
    J Cell Biochem; 2013 Jul; 114(7):1488-97. PubMed ID: 23296977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
    Qiao M; Shapiro P; Kumar R; Passaniti A
    J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.